Historiographs |
Grand Totals: LCS 913, GCS 17300 Collection span: 1946 - 2007 | |
Title Word List (900) Word count: 2384, All words count: 3643 |
# | Word | Recs | TLCS | TGCS |
---|---|---|---|---|
201 | PARENTAL | 3 | 1 | 109 |
202 | GAIN | 1 | 3 | 108 |
203 | REINFORCER | 1 | 3 | 108 |
204 | RELATION | 3 | 3 | 108 |
205 | BODY-WEIGHT | 4 | 5 | 107 |
206 | DEVELOPMENT | 3 | 6 | 107 |
207 | DIFFERENTIAL | 1 | 3 | 106 |
208 | SURGERY | 3 | 17 | 106 |
209 | HIGH | 3 | 10 | 104 |
210 | INVESTIGATION | 3 | 14 | 104 |
211 | REGIMENS | 3 | 13 | 104 |
212 | AGENTS | 1 | 5 | 103 |
213 | INCIDENCE | 1 | 13 | 103 |
214 | LOWER | 1 | 5 | 103 |
215 | POINT | 1 | 5 | 103 |
216 | SET | 1 | 5 | 103 |
217 | BODY-COMPOSITION | 2 | 6 | 102 |
218 | COMPLEX | 2 | 3 | 102 |
219 | MODEL | 4 | 4 | 102 |
220 | PATIENT | 2 | 13 | 101 |
221 | ASSESSMENT | 8 | 7 | 99 |
222 | GROUP | 5 | 11 | 99 |
223 | CHILDHOOD | 8 | 6 | 98 |
224 | DEPOSITION | 2 | 10 | 98 |
225 | 3-YEAR | 1 | 4 | 96 |
226 | NEUROENDOCRINE | 2 | 17 | 96 |
227 | THERAPEUTIC | 3 | 13 | 95 |
228 | COMPETITIONS | 3 | 5 | 94 |
229 | SELF-REPORTS | 1 | 3 | 94 |
230 | SMALL | 1 | 3 | 94 |
# | Word | Recs | TLCS | TGCS |
231 | PROGRAMS | 3 | 11 | 93 |
232 | ENERGY | 8 | 10 | 92 |
233 | PAIN | 1 | 9 | 92 |
234 | BLACK-ADOLESCENT | 1 | 1 | 88 |
235 | CLINICAL-TRIAL | 1 | 1 | 88 |
236 | COALITION | 1 | 13 | 88 |
237 | SUPPORT | 1 | 1 | 88 |
238 | VIEWS | 1 | 0 | 87 |
239 | HEALTH | 6 | 4 | 86 |
240 | FIGURE | 2 | 1 | 85 |
241 | PILOT | 3 | 11 | 85 |
242 | RECURRENT | 2 | 4 | 85 |
243 | PROMOTION | 3 | 4 | 84 |
244 | PROSPECTIVE | 5 | 3 | 84 |
245 | FAST | 2 | 5 | 83 |
246 | APPARENT | 1 | 5 | 82 |
247 | APPROACH | 3 | 4 | 82 |
248 | OBSERVATION | 1 | 7 | 82 |
249 | ACCOMPANYING | 1 | 8 | 81 |
250 | JEJUNOILEAL | 2 | 5 | 81 |
251 | ATTRITION | 2 | 10 | 80 |
252 | DISCONTENT | 1 | 1 | 80 |
253 | DISSATISFACTION | 1 | 1 | 80 |
254 | DSM-IV | 2 | 2 | 80 |
255 | RANDOMIZED | 3 | 1 | 80 |
256 | GENES | 3 | 3 | 78 |
257 | 40-YEAR | 1 | 0 | 77 |
258 | COMPREHENSIVE | 1 | 3 | 77 |
259 | FAMILIAL | 4 | 4 | 77 |
260 | FAMILY | 2 | 3 | 77 |
# | Word | Recs | TLCS | TGCS |
261 | LIFETIME | 1 | 0 | 77 |
262 | MEASUREMENT | 4 | 8 | 77 |
263 | MORBIDITY | 1 | 0 | 77 |
264 | MORTALITY | 1 | 0 | 77 |
265 | PATH | 1 | 3 | 77 |
266 | SHAVED | 1 | 3 | 77 |
267 | STOCKHOLM | 1 | 0 | 77 |
268 | FOLLOWING | 2 | 7 | 75 |
269 | INFANTS | 2 | 12 | 75 |
270 | STIGMATIZATION | 4 | 1 | 75 |
271 | VERY-LOW-CALORIE | 3 | 2 | 75 |
272 | SCALE | 1 | 1 | 74 |
273 | DEXAMPHETAMINE | 1 | 4 | 72 |
274 | MORBIDLY | 1 | 4 | 72 |
275 | PSYCHIATRIC-DIAGNOSIS | 1 | 4 | 72 |
276 | SULPHATE | 1 | 4 | 72 |
277 | PERSONAL | 1 | 0 | 70 |
278 | COUPLES | 1 | 4 | 69 |
279 | TRAINING | 1 | 4 | 69 |
280 | COST-EFFECTIVENESS | 1 | 4 | 68 |
281 | IMPACT | 1 | 4 | 68 |
282 | MORALE | 1 | 4 | 68 |
283 | PROGRAM | 3 | 2 | 68 |
284 | PSYCHOSOCIAL | 2 | 0 | 68 |
285 | MOOD | 4 | 0 | 67 |
286 | OBJECTIVE | 1 | 5 | 67 |
287 | PSYCHOPATHOLOGY | 1 | 2 | 67 |
288 | ANALYSIS | 5 | 5 | 66 |
289 | LONDON | 1 | 4 | 66 |
290 | CARDIOVASCULAR-DISEASE | 1 | 0 | 65 |
# | Word | Recs | TLCS | TGCS |
291 | CRITICAL-REVIEW | 2 | 3 | 65 |
292 | NUMBER | 1 | 0 | 65 |
293 | PREGNANCIES | 1 | 0 | 65 |
294 | PSYCHOANALYSIS | 3 | 5 | 65 |
295 | CORRELATES | 2 | 2 | 64 |
296 | MASS | 4 | 0 | 64 |
297 | SHORT-TERM | 2 | 0 | 64 |
298 | DETERMINANT | 1 | 9 | 63 |
299 | DETERMINATION | 1 | 0 | 63 |
300 | HUMAN-PLASMA | 1 | 0 | 63 |
301 | NET | 1 | 9 | 63 |
302 | OUTPUT | 1 | 9 | 63 |
303 | STORED | 1 | 0 | 63 |
304 | ATTITUDES | 2 | 4 | 62 |
305 | COHORT | 2 | 2 | 62 |
306 | D-FENFLURAMINE | 1 | 5 | 62 |
307 | DEPRESSIVE | 2 | 2 | 62 |
308 | MARKED | 1 | 1 | 62 |
309 | MULTICENTER | 1 | 1 | 62 |
310 | NATIONAL | 1 | 2 | 62 |
311 | POPULATION | 4 | 11 | 62 |
312 | PROPRIETARY | 1 | 1 | 62 |
313 | INVENTORY | 4 | 5 | 61 |
314 | PARENTS | 2 | 9 | 61 |
315 | RECOMMENDATIONS | 2 | 2 | 61 |
316 | CARE | 2 | 5 | 60 |
317 | COMMERCIAL | 1 | 7 | 60 |
318 | DIMENSIONS | 2 | 1 | 60 |
319 | FLEXIBLE | 1 | 1 | 60 |
320 | RATES | 1 | 7 | 60 |
# | Word | Recs | TLCS | TGCS |
321 | RIGID | 1 | 1 | 60 |
322 | USING | 4 | 0 | 60 |
323 | BEHAVIORAL-CHANGES | 1 | 7 | 59 |
324 | EMOTIONAL | 1 | 5 | 59 |
325 | METHODS | 1 | 5 | 59 |
326 | APPETITE | 3 | 5 | 58 |
327 | ENVIRONMENTAL | 2 | 6 | 58 |
328 | UNDERSTANDING | 2 | 2 | 58 |
329 | COMPUTED-TOMOGRAPHY | 1 | 0 | 57 |
330 | FEASIBILITY | 1 | 0 | 57 |
331 | ILL | 2 | 0 | 57 |
332 | MODERATE | 2 | 2 | 57 |
333 | MEDICALLY | 1 | 0 | 56 |
334 | METABOLIC | 2 | 1 | 56 |
335 | SCIENTIFIC | 1 | 0 | 56 |
336 | YEARS | 5 | 6 | 56 |
337 | ADOPTIVE | 1 | 5 | 55 |
338 | CORRELATIONS | 1 | 5 | 55 |
339 | GETTING | 1 | 1 | 55 |
340 | RELATIVES | 1 | 5 | 55 |
341 | WORSE | 1 | 1 | 55 |
342 | REFLEX | 3 | 0 | 54 |
343 | CONSISTENCY | 1 | 4 | 53 |
344 | DIRECTION | 1 | 4 | 53 |
345 | EPISODES | 1 | 4 | 53 |
346 | FENFLURAMINE | 2 | 1 | 53 |
347 | WORK-SITE | 1 | 5 | 53 |
348 | DENIAL | 2 | 2 | 52 |
349 | SENSITIVITY | 2 | 4 | 52 |
350 | CONSENT | 1 | 0 | 50 |
# | Word | Recs | TLCS | TGCS |
351 | DANGER | 1 | 0 | 50 |
352 | DOUBLE-BLIND | 2 | 0 | 50 |
353 | ENERGY-EXPENDITURE | 1 | 3 | 50 |
354 | EXCESS | 1 | 3 | 50 |
355 | FEMALE | 5 | 4 | 50 |
356 | INFORMED | 1 | 0 | 50 |
357 | CHILDRENS | 1 | 6 | 49 |
358 | EARLIER | 1 | 6 | 49 |
359 | PHARMACOLOGIC | 1 | 4 | 49 |
360 | POTENTIAL | 1 | 4 | 49 |
361 | PRIMARY | 1 | 4 | 49 |
362 | RECALL | 1 | 6 | 49 |
363 | CONTROLLED-STUDY | 1 | 3 | 48 |
364 | LESS | 1 | 3 | 48 |
365 | MODIFIED | 1 | 3 | 48 |
366 | PROTEIN-SPARING | 1 | 3 | 48 |
367 | ENVIRONMENTAL-INFLUENCES | 1 | 3 | 47 |
368 | LONGITUDINAL | 1 | 3 | 47 |
369 | ADOLESCENT | 2 | 4 | 46 |
370 | COMMINGLING | 1 | 5 | 45 |
371 | COMPARISON | 5 | 3 | 45 |
372 | APPETITIVE | 1 | 3 | 44 |
373 | CONSERVATIVE | 1 | 2 | 44 |
374 | GENERAL | 1 | 10 | 44 |
375 | POSTOPERATIVE | 1 | 10 | 44 |
376 | TREATMENTS | 1 | 2 | 44 |
377 | CONDITIONED | 1 | 0 | 43 |
378 | REGAIN | 1 | 0 | 43 |
379 | GLUCOSE | 4 | 2 | 42 |
380 | COMPONENTS | 1 | 6 | 41 |
# | Word | Recs | TLCS | TGCS |
381 | EARLY | 2 | 6 | 41 |
382 | PERFORMANCE | 1 | 4 | 41 |
383 | SOCIODEMOGRAPHIC | 1 | 6 | 41 |
384 | INTRAVENOUS | 3 | 3 | 40 |
385 | DISORDERED | 3 | 4 | 39 |
386 | MARKER | 3 | 4 | 39 |
387 | ADMINISTRATION | 2 | 3 | 38 |
388 | EMOTIONS | 1 | 5 | 38 |
389 | PHYSICAL-ACTIVITY | 1 | 5 | 38 |
390 | PHYSIOLOGY | 2 | 3 | 38 |
391 | ADHERENCE | 2 | 3 | 36 |
392 | NALTREXONE | 1 | 0 | 36 |
393 | FIRST | 4 | 7 | 35 |
394 | OLD | 6 | 2 | 35 |
395 | PROTEIN-FORMULA-LIQUID | 1 | 2 | 35 |
396 | PROTEIN-SPARING-MODIFIED | 1 | 2 | 35 |
397 | STYLE | 2 | 2 | 35 |
398 | MOTILITY | 2 | 2 | 34 |
399 | NON-OBESE | 1 | 3 | 34 |
400 | QUALITY-OF-LIFE | 1 | 0 | 34 |